Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Y chromosome haplotypes and prostate cancer in Sweden.

Lindström S, Adami HO, Adolfsson J, Wiklund F.

Clin Cancer Res. 2008 Oct 15;14(20):6712-6. doi: 10.1158/1078-0432.CCR-08-0658.

2.

Lack of association between Y-chromosomal haplogroups and prostate cancer in the Korean population.

Kim W, Yoo TK, Kim SJ, Shin DJ, Tyler-Smith C, Jin HJ, Kwak KD, Kim ET, Bae YS.

PLoS One. 2007 Jan 24;2(1):e172.

3.

A Y chromosomal influence on prostate cancer risk: the multi-ethnic cohort study.

Paracchini S, Pearce CL, Kolonel LN, Altshuler D, Henderson BE, Tyler-Smith C.

J Med Genet. 2003 Nov;40(11):815-9.

4.

Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.

Severi G, Hayes VM, Neufing P, Padilla EJ, Tilley WD, Eggleton SA, Morris HA, English DR, Southey MC, Hopper JL, Sutherland RL, Boyle P, Giles GG.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1142-7.

5.

Prostate cancer incidence varies among males from different Y-chromosome lineages.

Ewis AA, Lee J, Naroda T, Sano T, Kagawa S, Iwamoto T, Shinka T, Shinohara Y, Ishikawa M, Baba Y, Nakahori Y.

Prostate Cancer Prostatic Dis. 2006;9(3):303-9. Epub 2006 May 9.

PMID:
16683011
6.

Estrogen receptor beta polymorphism is associated with prostate cancer risk.

Thellenberg-Karlsson C, Lindström S, Malmer B, Wiklund F, Augustsson-Bälter K, Adami HO, Stattin P, Nilsson M, Dahlman-Wright K, Gustafsson JA, Grönberg H.

Clin Cancer Res. 2006 Mar 15;12(6):1936-41.

7.

Genetic Susceptibility to Prostate Cancer: Prostate-specific Antigen and its Interaction with the Androgen Receptor (United States).

Sieh W, Edwards KL, Fitzpatrick AL, Srinouanprachanh SL, Farin FM, Monks SA, Kronmal RA, Eaton DL.

Cancer Causes Control. 2006 Mar;17(2):187-97.

PMID:
16425097
8.

Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.

Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, Robbins C, Isaacs SD, Cheng Y, Li G, Sun J, Chang BL, Marovich L, Wiley KE, Bälter K, Stattin P, Adami HO, Gielzak M, Yan G, Sauvageot J, Liu W, Kim JW, Bleecker ER, Meyers DA, Trock BJ, Partin AW, Walsh PC, Isaacs WB, Grönberg H, Xu J, Carpten JD.

J Natl Cancer Inst. 2007 Dec 19;99(24):1836-44. Epub 2007 Dec 11.

9.

Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.

Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ.

Cancer Res. 2005 Dec 15;65(24):11771-8.

10.

Influence of MUC1 genetic variation on prostate cancer risk and survival.

Strawbridge RJ, Nister M, Brismar K, Li C, Lindström S.

Eur J Hum Genet. 2008 Dec;16(12):1521-5. doi: 10.1038/ejhg.2008.131. Epub 2008 Jul 16.

11.

H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.

Lindmark F, Zheng SL, Wiklund F, Bensen J, Bälter KA, Chang B, Hedelin M, Clark J, Stattin P, Meyers DA, Adami HO, Isaacs W, Grönberg H, Xu J.

J Natl Cancer Inst. 2004 Aug 18;96(16):1248-54.

12.

Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk: a replication study in an ethnically homogeneous population.

FitzGerald LM, Thomson R, Polanowski A, Patterson B, McKay JD, Stankovich J, Dickinson JL.

Prostate. 2008 Sep 15;68(13):1373-9. doi: 10.1002/pros.20798.

PMID:
18537123
13.

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness.

Casey G, Neville PJ, Liu X, Plummer SJ, Cicek MS, Krumroy LM, Curran AP, McGreevy MR, Catalona WJ, Klein EA, Witte JS.

Hum Mol Genet. 2006 Mar 1;15(5):735-41. Epub 2006 Jan 24.

14.

The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study.

Severi G, Hayes VM, Padilla EJ, English DR, Southey MC, Sutherland RL, Hopper JL, Giles GG.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):610-2.

15.

Cumulative association of five genetic variants with prostate cancer.

Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Bälter K, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Grönberg H.

N Engl J Med. 2008 Feb 28;358(9):910-9. doi: 10.1056/NEJMoa075819. Epub 2008 Jan 16.

16.

Lactase persistence, dietary intake of milk, and the risk for prostate cancer in Sweden and Finland.

Torniainen S, Hedelin M, Autio V, Rasinperä H, Bälter KA, Klint A, Bellocco R, Wiklund F, Stattin P, Ikonen T, Tammela TL, Schleutker J, Grönberg H, Järvelä I.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):956-61.

17.

Replication of prostate cancer risk loci in a Japanese case-control association study.

Yamada H, Penney KL, Takahashi H, Katoh T, Yamano Y, Yamakado M, Kimura T, Kuruma H, Kamata Y, Egawa S, Freedman ML.

J Natl Cancer Inst. 2009 Oct 7;101(19):1330-6. doi: 10.1093/jnci/djp287. Epub 2009 Sep 2.

18.

A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.

Nam RK, Zhang WW, Loblaw DA, Klotz LH, Trachtenberg J, Jewett MA, Stanimirovic A, Davies TO, Toi A, Venkateswaran V, Sugar L, Siminovitch KA, Narod SA.

Prostate Cancer Prostatic Dis. 2008;11(3):241-6. Epub 2007 Sep 18.

PMID:
17876339
19.

Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.

Sun J, Lange EM, Isaacs SD, Liu W, Wiley KE, Lange L, Gronberg H, Duggan D, Carpten JD, Walsh PC, Xu J, Chang BL, Isaacs WB, Zheng SL.

Prostate. 2008 Apr 1;68(5):489-97. doi: 10.1002/pros.20695.

PMID:
18213635
20.

Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk.

Johansson M, McKay JD, Wiklund F, Rinaldi S, Hallmans G, Bälter K, Adami HO, Grönberg H, Stattin P, Kaaks R.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1644-50. doi: 10.1158/1055-9965.EPI-08-0893.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk